Literature DB >> 28112082

A novel blood test for tuberculosis prevention and treatment.

A Penn-Nicholson1, T J Scriba, M Hatherill, R G White, T Sumner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28112082     DOI： 10.7196/SAMJ.2016.v107.i1.12230

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  7 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

Review 2.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

Review 3.  Defining a migrant-inclusive tuberculosis research agenda to end TB.

Authors:  P B Shete; D Boccia; P Dhavan; N Gebreselassie; K Lönnroth; S Marks; A Matteelli; D L Posey; M J van der Werf; C A Winston; C Lienhardt
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

4.  Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.

Authors:  Sara Suliman; Ethan G Thompson; Jayne Sutherland; January Weiner; Martin O C Ota; Smitha Shankar; Adam Penn-Nicholson; Bonnie Thiel; Mzwandile Erasmus; Jeroen Maertzdorf; Fergal J Duffy; Philip C Hill; E Jane Hughes; Kim Stanley; Katrina Downing; Michelle L Fisher; Joe Valvo; Shreemanta K Parida; Gian van der Spuy; Gerard Tromp; Ifedayo M O Adetifa; Simon Donkor; Rawleigh Howe; Harriet Mayanja-Kizza; W Henry Boom; Hazel M Dockrell; Tom H M Ottenhoff; Mark Hatherill; Alan Aderem; Willem A Hanekom; Thomas J Scriba; Stefan H E Kaufmann; Daniel E Zak; Gerhard Walzl
Journal:  Am J Respir Crit Care Med       Date:  2018-05-01       Impact factor: 30.528

5.  Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy.

Authors:  Tom Sumner; Thomas J Scriba; Adam Penn-Nicholson; Mark Hatherill; Richard G White
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

6.  Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.

Authors:  Thomas J Scriba; Andrew Fiore-Gartland; Adam Penn-Nicholson; Humphrey Mulenga; Stanley Kimbung Mbandi; Bhavesh Borate; Simon C Mendelsohn; Katie Hadley; Chris Hikuam; Masooda Kaskar; Munyaradzi Musvosvi; Nicole Bilek; Steven Self; Tom Sumner; Richard G White; Mzwandile Erasmus; Lungisa Jaxa; Rodney Raphela; Craig Innes; William Brumskine; Andriëtte Hiemstra; Stephanus T Malherbe; Razia Hassan-Moosa; Michèle Tameris; Gerhard Walzl; Kogieleum Naidoo; Gavin Churchyard; Mark Hatherill
Journal:  Lancet Infect Dis       Date:  2021-01-25       Impact factor: 71.421

7.  Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention.

Authors:  Andrew Fiore-Gartland; Lindsay N Carpp; Kogieleum Naidoo; Ethan Thompson; Daniel E Zak; Steve Self; Gavin Churchyard; Gerhard Walzl; Adam Penn-Nicholson; Thomas J Scriba; Mark Hatherill
Journal:  Tuberculosis (Edinb)       Date:  2017-11-22       Impact factor: 3.131
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.